Actual Big Pharma CEO email: ‘We raised the price from $1,700 per bottle to $75,000. Should be a very handsome investment for all of us’
by: Sarah Landers
NaturalNews.com
Tuesday, February 09, 2016
Concerning documents that have recently come to light reveal drug firm schemes to maximize profits on medicine that is used to treat cancer, AIDS and heart conditions. A congressional review of more than 300,000 pages from Turing Pharmaceuticals and Valeant Pharmaceuticals reveals how executives planned to maximize profits while fending off negative publicity over the price hikes.
The two drugmakers have made a practice of buying and then dramatically hiking the prices of low-cost drugs given to patients with life-threatening conditions – according to excerpts from thousands of documents released by federal lawmakers.
The investigation into jacked up prices from Turing Pharmaceuticals
Rep. Elijah Cummings of the House Committee on Oversight and Government Reform released the information ahead of a hearing last week to examine the extortionate price spikes by several companies that have previously bought low-cost drugs and jacked up the prices.
The Democrat said in a statement that the documents show “that many drug companies are lining their pockets at the expense of some of the most vulnerable families in our nation.”
The Rest…HERE
